DTRMWXHS‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study.

Details

Language :

English

ISSN :

03618609

Volume :

98

Issue :

5

Database :

Complementary Index

Journal :

American Journal of Hematology

Publication Type :

Academic Journal

Accession number :

163021540

Full Text :

https://doi.org/10.1002/ajh.26888